I am getting malaria every 6 months

QUESTION:

I am getting malaria every six months, after taken chloroquine medicine tablets. Is this  normal,when my resistance is low, or is it coming aging, is there any medicine to clear the malaria?

ANSWER:

While taking chloroquine can be used to treat malaria, it will not prevent re-infection, unfortunately. One thing to check though is whether you are living in an area where the local types of malaria might be resistant to chloroquine; if so, it will be worth seeing if you can be treated with artemisinin-based combination therapies (ACTs), such as Coartem or Lonart, instead.

Again, these will not prevent re-infection, however, so you need to also take other preventative actions, such as sleeping under a long-lasting insecticide treated bednet and wearing long-sleeved clothing in the evenings and at night to prevent mosquito bites.

It sounds from your question like you live in an area where malaria is common; however, if you are actually only travelling to malarial areas regularly, you could also ask your doctor about the possibility of taking preventative medicine against malaria for the time that you are travelling (these are called “prophylactics”).

You should also check which species of malaria parasite you are infected with – this can be determined when you are diagnosed with the infection, either through looking at your blood under a microscope or by using a rapid diagnostic test (RDT). If you Plasmodium ovale or Plasmodium vivax, there is a possibility that even though the initial acute phase of the infection is responding to treatment with chloroquine, the parasite is remaining dormant in your liver, and causing the recurrences every 6 months. In this case, you should ask your doctor about the possibility of taking a drug called primaquine, which kills these liver stages and prevents further relapse of the disease.

RTS,S Malaria Vaccine

QUESTION:

What information can you provide on this vaccine candidate?

ANSWER:

RTS,S is a vaccine candidate against Plasmodium falciparum malaria which works by encouraging the host’s body to produce antibodies and T cells which diminish the malaria parasite’s ability to survive and reproduce in the liver.

Produced by GlaxoSmithKline, RTS,S is the first vaccine candidate against Plasmodium falciparum that has reached advanced (Phase III) clinical field trials on a large scale. It was developed way back in 1987, and had successive trials in the United States in 1992 and then in Africa in 1998. In 2001, GSK and the Malaria Vaccine Initiative at PATH went into a public-private partnership, with grant money from the Bill and Melinda Gates Foundation, to develop the vaccine for use in children and infants in sub-Saharan Africa.

The Phase III trials are currently underway in a number of African countries; if all goes to plan, the vaccine will be submitted for regulation by drug authorities as early as 2012. This information, and more, can be found courtesy of the Malaria Vaccine Initiative website: http://www.malariavaccine.org/index.php.

What can I do to help?

QUESTION:

What is there I can do to help them?

ANSWER:

Thank you for your concern! Probably the easiest and most direct way you can support the people suffering from malaria infections, especially in the developing world, is by helping to spread awareness about the impact of the disease and how it affects millions of people worldwide.

To help with these campaigns, you can also donate to organisations dedicated to fighting malaria, such as Malaria No More, or the Nothing But Nets campaign.

Finally, if you or people you know are going to be travelling to malarial areas, make sure that you are fully informed of the risks of malaria and take all the preventative actions that you should to make sure you yourself don’t get malaria as well!

How does malaria enter the body?

QUESTION:

What is the portal of entry for malaria?

ANSWER:

Malaria enters its human hosts via the bite of mosquitoes of the genus Anopheles. The malaria parasites are present in the mosquitoes saliva, and enter into the human bloodstream when the mosquito bites to take a blood meal.

Once in the human body, the malaria parasite then undergoes a number of different life stages, involving reproduction in the liver as well as inside red blood cells. Once the malaria parasite has undergone reproduction in the red blood cells, the new parasites burst out and back into the blood stream, where they can be ingested by another mosquito biting again. Inside the mosquito, the malaria parasites undergo more reproduction and life stage changes, until they are ready to be transferred into a human host again, via another bite. In this way, the cycle continues.

Malaria and Economics

QUESTION:

Why is malaria the most important cause of economic distress?

ANSWER:

While malaria is clearly a huge burden on many aspects of society, including economies, in many parts of the world, I’m not sure it’s fair to say that it’s the leading cause of economic distress. However, it certainly contributes to slow economic progress, through mechanisms related to the “poverty trap” hypothesis developed by Jeffrey Sachs, a professor at Colombia University in New York City.

Sachs believes that factors such as disease ecology, and especially if magnified through poor public health policy and weak health infrastructure, interact with other variables such as governance and natural resource distribution to create negative feedback loops that lock a country or a region in poverty.

For health specifically, the argument is that people who are sick are more likely to miss work, or school in the case of children, or be less productive even if they do go, because of their illness. This loss of working adults and loss of education for children results in a slower economy and makes it harder for a country to grow and develop. Given that malaria is one of the developing world’s most prevalent and deadly diseases, it certainly makes up a large contribution to this portion of the poverty trap, but other high burden infections such as HIV/AIDS, diarrheal illnesses and worms also contribute heavily.

Malaria Infection Possibilities?

QUESTION:

How can malaria affect somebody if you far from mosquitoes?

ANSWER:

It is extremely unlikely for you to become infected with malaria unless you are bitten by an infected mosquito. In rare caces, there have been reports of people contracting malaria through blood transfusions, but in most places, blood donors with a history of malaria are not allowed to donate whole blood, and only plasma, thus preventing transmission through this route.

ARCEVA for malaria

QUESTION:

Is ARCEVA a good vaccine for malaria?

ANSWER:

ARCEVA isn’t a vaccine for malaria, but it is a brand name of one type of medication used to treat the disease. It belongs to the group of drugs called artemisinin-based combination therapies (ACTs), which are recommended by the World Health Organisation to treat uncomplicated malaria caused by Plasmodium falciparum, the most dangerous form of malaria. ARCEVA specifically contains artemether combined with lumefantrine. It is very important to know that there is no effective vaccine against malaria that is currently available; many scientists and researchers are vigorously hunting for such a vaccine, knowing that this would radically decrease the number of cases of malaria worldwide.

Symptoms of Malaria

QUESTION:

SYMPTOMS OF MALARIA?

ANSWER:

The symptoms of malaria include fever and flu-like illness, including shaking chills, headache, muscle aches, and tiredness. Nausea, vomiting, and diarrhea may also occur. Malaria may cause anemia and jaundice (yellow coloring of the skin and eyes) because of the loss of red blood cells. Infection with one type of malaria, Plasmodium falciparum, if not promptly treated, may cause kidney failure, seizures, mental confusion, coma, and death.

BT and MT Malaria

QUESTION:

What is MT and BT malaria?

ANSWER:

“MT” stands for “malignant tertian” and “BT” stands for “benign tertian” malaria. Tertian malaria describes fever which occurs every other day, in cycles. Of the main types of human malaria, Plasmodium vivax and Plasmodium ovale are the most stereotypically tertian. P. falciparum can be tertian, but it is more erratic and due to its severity, can result in increased frequency of fever. “Malignant” and “benign” refers to the severity of the disease. Malignant malaria is severe and sometimes fatal, whereas benign malaria is less acute and rarely results in death.

Discovery of Mosquito Causing Malaria

QUESTION:

Who found that malaria was caused by a mosquito?

ANSWER:

The man who first discovered that malaria was transmitted by mosquitoes was a British Army doctor called Ronald Ross. Working in India in 1897-1898, Ross demonstrated how malaria parasites could be transmitted first between a patient and a mosquito, and then between hosts via mosquitoes (this latter work was done using birds). Ronald Ross was honoured with the Nobel Prize in 1902 for his discoveries.